86.35
price up icon1.14%   0.97
after-market アフターアワーズ: 86.00 -0.35 -0.41%
loading
前日終値:
$85.38
開ける:
$85.46
24時間の取引高:
1.99M
Relative Volume:
1.16
時価総額:
$42.71B
収益:
$9.93B
当期純損益:
$1.12B
株価収益率:
38.38
EPS:
2.25
ネットキャッシュフロー:
$1.58B
1週間 パフォーマンス:
+0.24%
1か月 パフォーマンス:
-10.44%
6か月 パフォーマンス:
-2.81%
1年 パフォーマンス:
-1.17%
1日の値動き範囲:
Value
$85.09
$86.91
1週間の範囲:
Value
$84.94
$87.64
52週間の値動き範囲:
Value
$80.48
$101.10

Alcon Inc Stock (ALC) Company Profile

Name
名前
Alcon Inc
Name
セクター
Healthcare (1177)
Name
電話
-
Name
住所
-
Name
職員
25,599
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
ALC's Discussions on Twitter

ALC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Instruments & Supplies icon
ALC
Alcon Inc
86.35 42.61B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
555.75 194.50B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
173.82 49.39B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
RMD
Resmed Inc
245.12 36.00B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
COO
The Cooper Companies, Inc.
79.96 15.86B 3.93B 415.40M 384.70M 2.06

Alcon Inc Stock (ALC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-20 ダウングレード Deutsche Bank Buy → Hold
2025-05-14 繰り返されました BTIG Research Buy
2025-03-28 繰り返されました Needham Buy
2025-03-25 アップグレード BofA Securities Neutral → Buy
2025-01-24 繰り返されました Needham Buy
2025-01-10 アップグレード Redburn Atlantic Neutral → Buy
2024-12-17 繰り返されました Needham Buy
2024-11-12 繰り返されました Needham Buy
2024-10-10 アップグレード Redburn Atlantic Sell → Neutral
2024-09-10 アップグレード RBC Capital Mkts Sector Perform → Outperform
2024-07-15 アップグレード Morgan Stanley Underweight → Equal-Weight
2024-05-15 アップグレード Oppenheimer Perform → Outperform
2024-04-10 開始されました Goldman Buy
2024-03-14 開始されました RBC Capital Mkts Sector Perform
2024-02-06 再開されました KeyBanc Capital Markets Overweight
2024-01-23 開始されました Bernstein Outperform
2023-12-18 ダウングレード Redburn Atlantic Neutral → Sell
2023-12-12 開始されました Stifel Buy
2023-12-04 ダウングレード Morgan Stanley Equal-Weight → Underweight
2023-08-17 アップグレード JP Morgan Neutral → Overweight
2023-05-30 再開されました Morgan Stanley Equal-Weight
2023-05-10 アップグレード Robert W. Baird Neutral → Outperform
2023-03-01 アップグレード Societe Generale Sell → Hold
2022-12-22 開始されました Mizuho Buy
2022-11-17 ダウングレード Societe Generale Hold → Sell
2022-08-11 ダウングレード Societe Generale Buy → Hold
2022-05-13 再開されました Credit Suisse Outperform
2022-05-12 アップグレード Stephens Equal-Weight → Overweight
2022-04-08 開始されました Needham Buy
2022-03-11 開始されました BofA Securities Buy
2022-01-18 ダウングレード Stephens Overweight → Equal-Weight
2022-01-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-10-01 開始されました Oppenheimer Perform
2021-07-14 開始されました Deutsche Bank Buy
2021-05-06 アップグレード Citigroup Sell → Neutral
2021-03-22 アップグレード BTIG Research Neutral → Buy
2020-11-12 ダウングレード Guggenheim Buy → Neutral
2020-07-06 ダウングレード Citigroup Neutral → Sell
2020-07-06 開始されました KeyBanc Capital Markets Sector Weight
2020-06-16 アップグレード Guggenheim Neutral → Buy
2020-04-08 ダウングレード Robert W. Baird Outperform → Neutral
2020-03-26 アップグレード Argus Hold → Buy
2020-03-24 アップグレード Societe Generale Sell → Hold
2020-03-13 アップグレード UBS Neutral → Buy
2020-03-05 開始されました Citigroup Neutral
2020-02-26 アップグレード Berenberg Hold → Buy
2020-01-08 開始されました Argus Hold
2019-10-29 開始されました Stephens Equal-Weight
2019-08-21 繰り返されました BofA/Merrill Neutral
2019-06-24 開始されました SVB Leerink Mkt Perform
2019-06-14 開始されました BTIG Research Neutral
2019-05-10 開始されました Robert W. Baird Outperform
2019-05-02 開始されました Credit Suisse Outperform
すべてを表示

Alcon Inc (ALC) 最新ニュース

pulisher
May 29, 2025

Alcon Inc. (ALC)’s TRYPTYR Wins FDA Nod for Dry Eye Disease - MSN

May 29, 2025
pulisher
May 29, 2025

FDA Approves Alcon’s Tryptyr for Dry Eye Disease - Managed Healthcare Executive

May 29, 2025
pulisher
May 29, 2025

Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Benzinga

May 29, 2025
pulisher
May 29, 2025

US FDA approves Alcon's new dry-eye drug - Reuters

May 29, 2025
pulisher
May 29, 2025

Alcon Stock Rises Following the FDA Approval of TRYPTYR - TradingView

May 29, 2025
pulisher
May 29, 2025

FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease - Ophthalmology Times

May 29, 2025
pulisher
May 29, 2025

Alcon up 4% as FDA approves Tryptyr drops for dry eye - MSN

May 29, 2025
pulisher
May 29, 2025

FDA approves Alcon’s TRYPTYR for Dry Eye Disease treatment By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

BTIG maintains Alcon $99 target, upbeat on TRYPTYR launch - Investing.com

May 29, 2025
pulisher
May 28, 2025

US FDA Approves Alcon's Dry Eye Disease Treatment - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

US FDA approves Alcon’s new dry-eye drug - The Mighty 790 KFGO

May 28, 2025
pulisher
May 28, 2025

Alcon (ALC) Gains FDA Approval for Innovative Dry Eye Treatment - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic s - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Alcon (ALC) Gains FDA Nod for Innovative Dry Eye Treatment | ALC Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

FDA approves Alcon’s TRYPTYR for Dry Eye Disease treatment - Investing.com

May 28, 2025
pulisher
May 28, 2025

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Gordon Schanzlin New Vision Institute First in Region to Offer Groundbreaking Alcon Sitemap Technology for Personalized Vision Correction - GlobeNewswire Inc.

May 28, 2025
pulisher
May 28, 2025

BTIG maintains Alcon stock Buy rating, $99 target By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 27, 2025

WeMade Files Antitrust Complaint Against South Korea’s Major Crypto Exchanges - PYMNTS.com

May 27, 2025
pulisher
May 27, 2025

BTIG maintains Alcon stock Buy rating, $99 target - Investing.com

May 27, 2025
pulisher
May 26, 2025

Turkey Contact Lens MarketCompetition, Forecast & Opportunities to 2030, Featuring Tech Contactlens, Diafarma, Alcon Laboratories, Diplomat Optics, Hoya Turkiye, ZEISS Turkiye, Keralens & more - Yahoo

May 26, 2025
pulisher
May 26, 2025

U.S. Ophthalmic Photocoagulator Growth Trends and Forecasts 2025-2032 - GlobeNewswire Inc.

May 26, 2025
pulisher
May 25, 2025

FTC Requests More Information on Alcon's $430 Million Acquisition of Lensar - PYMNTS.com

May 25, 2025
pulisher
May 23, 2025

FTC Probing Alcon's $430M Lensar Deal - Law360

May 23, 2025
pulisher
May 23, 2025

Stifel Nicolaus Reaffirms Their Buy Rating on Alcon (ALC) - The Globe and Mail

May 23, 2025
pulisher
May 22, 2025

Eye care product makers Alcon, LENSAR get second request from US FTC - MLex

May 22, 2025
pulisher
May 22, 2025

Alcon (ALC) Receives Upgrade to Buy from Kepler Cheuvreux | ALC Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Alcon Inc. (NYSE:ALC) Q1 2025 Earnings Call Transcript - MSN

May 22, 2025
pulisher
May 21, 2025

Alcon (ALC): A Key Partner in Lifecore's Revenue Growth Strategy - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Alcon (ALC): A Key Partner in Lifecore's Revenue Growth Strategy | ALC Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Alcon (VTX:ALC) Strong Profits May Be Masking Some Underlying Issues - simplywall.st

May 21, 2025
pulisher
May 21, 2025

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Alcon (ALC) - The Globe and Mail

May 21, 2025
pulisher
May 21, 2025

Alcon's (VTX:ALC) Profits May Not Reveal Underlying Issues - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

RBC cuts Alcon stock price target to CHF95, keeps Outperform rating - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

RBC Capital Adjusts Price Target for Alcon (ALC) While Maintaining Optimism | ALC Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Stifel maintains Alcon stock Buy rating, $100 target amid new drug launch - Investing.com Nigeria

May 20, 2025
pulisher
May 20, 2025

Deutsche Bank Downgrades Alcon (ALC) Rating, Lowers Price Target | ALC Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Deutsche Bank cuts Alcon stock rating, lowers price target - Investing.com

May 20, 2025
pulisher
May 20, 2025

Deutsche Bank cuts Alcon stock rating, lowers price target By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 20, 2025

RBC cuts Alcon stock price target to CHF95, keeps Outperform rating By Investing.com - Investing.com South Africa

May 20, 2025
pulisher
May 19, 2025

LENSAR Announces Merger with Alcon Research - TipRanks

May 19, 2025
pulisher
May 18, 2025

Alcon updates 2025 sales growth target to 6%-7% driven by new product launches and tariff mitigation - MSN

May 18, 2025
pulisher
May 16, 2025

Alcon stock target cut to $109 by Bernstein on Q2 outlook - Investing.com Nigeria

May 16, 2025
pulisher
May 15, 2025

Alcon’s Earnings Call: Balancing Growth and Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Alcon (ALC) Sees Notable Increase in Borrow Rate | ALC Stock New - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Alcon Revises Outlook As Swiss Market Stays Steady - Finimize

May 15, 2025
pulisher
May 15, 2025

India Ophthalmic Devices Market Forecast Report 2025-2033, Competitive Analysis of Alcon, Bausch Health, Carl Zeiss, Meditec, Essilor, Hoya, Johnson & Johnson, Nidek, Topcon - Yahoo

May 15, 2025

Alcon Inc (ALC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_instruments_supplies RMD
$245.12
price up icon 0.15%
medical_instruments_supplies BDX
$173.82
price up icon 0.47%
medical_instruments_supplies COO
$79.96
price down icon 0.20%
medical_instruments_supplies BAX
$30.70
price up icon 0.39%
medical_instruments_supplies WST
$210.46
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):